← 28 September 2026's Current Affairs · Karnataka GS-2 Prelims ★★★★☆ Mains ★★★★☆
Karnataka flags steep markups on critical drugs
ಸುದ್ದಿಯಲ್ಲಿ ಏಕೆ?
Cancer drugs marked up 70 times over cost: the price-control law meant to stop this
Karnataka's Health Minister flagged markups of up to 70 times procurement cost on critical drugs, citing weak price-control enforcement.
Why it matters: GS-2 core; factual, Prelims-type; Karnataka-specific
What you need to know
2 ನಿಮಿಷ
Karnataka's Health Minister said that some cancer, kidney and HIV/AIDS medications were being sold to patients at markups of up to 70 times their procurement cost in private hospitals and pharmacies, and flagged the need for stronger price controls.
Drug pricing in India for essential medicines is regulated by the National Pharmaceutical Pricing Authority (NPPA) under the Drugs (Prices Control) Order, which caps trade margins on certain formulations.
The Minister's remarks pointed to gaps in enforcement for high-cost critical-illness drugs.
ಮೂಲಗಳು: Topper IAS editorial (PIB / The Hindu / Indian Express)
ಮುಖ್ಯ ಅಂಶಗಳು
Remember these
- Karnataka's Health Minister flagged markups of up to 70 times procurement cost on some critical drugs
- Cancer, kidney and HIV/AIDS medications named as commonly overpriced in private hospitals and pharmacies
- NPPA regulates essential drug prices under the Drugs (Prices Control) Order
- The Order caps trade margins on certain scheduled formulations
- Minister pointed to weak enforcement for high-cost critical-illness drugs
ಪ್ರಿಲಿಮ್ಸ್ · ಮೇನ್ಸ್
How the exam will ask it
ಪ್ರಿಲಿಮ್ಸ್
- Karnataka's Health Minister flagged markups of up to 70 times procurement cost on certain cancer, kidney and HIV/AIDS drugs sold in private hospitals and pharmacies.
- The National Pharmaceutical Pricing Authority (NPPA) regulates prices of essential and scheduled medicines under the Drugs (Prices Control) Order.
- The Drugs (Prices Control) Order caps trade margins on certain drug formulations to prevent overpricing.
- The Minister's remarks highlighted gaps in enforcement of price controls for high-cost critical-illness drugs.
ಮೇನ್ಸ್
GS Paper 2 - Governance/Health policy: unchecked markups on critical-illness drugs expose gaps in enforcing the NPPA's mandate under the Drugs (Prices Control) Order, raising patients' out-of-pocket burden and undermining affordable healthcare access. The way forward lies in extending trade-margin caps to more critical formulations, strengthening state-level price monitoring, and coordinating Centre-State action against violations.
Quick recall
Answer before you reveal
ಕರ್ನಾಟಕದಲ್ಲಿ ಔಷಧಗಳ ಹೆಚ್ಚಿನ ಬೆಲೆ ಏರಿಕೆಯ ಬಗ್ಗೆ ಎತ್ತಿದ ಕಳವಳಕ್ಕೆ ಸಂಬಂಧಿಸಿದಂತೆ, ಭಾರತದಲ್ಲಿ ಅಗತ್ಯ ಔಷಧಗಳ ಬೆಲೆ ಮತ್ತು ವ್ಯಾಪಾರ ಅಂಚನ್ನು ನಿಯಂತ್ರಿಸುವ ಕೇಂದ್ರ ನಿಯಂತ್ರಕ ಯಾವುದು?
- ಕೇಂದ್ರೀಯ ಔಷಧ ಗುಣಮಟ್ಟ ನಿಯಂತ್ರಣ ಸಂಸ್ಥೆ
- ರಾಷ್ಟ್ರೀಯ ಔಷಧೀಯ ಬೆಲೆ ನಿಗದಿ ಪ್ರಾಧಿಕಾರ
- ಭಾರತೀಯ ಆಹಾರ ಸುರಕ್ಷತೆ ಮತ್ತು ಗುಣಮಟ್ಟ ಪ್ರಾಧಿಕಾರ
- ಭಾರತೀಯ ಔಷಧಾಲಯ ಪರಿಷತ್ತು
ಉತ್ತರ ನೋಡಿ
ಉತ್ತರ: B — ಸರಿ: ರಾಷ್ಟ್ರೀಯ ಔಷಧೀಯ ಬೆಲೆ ನಿಗದಿ ಪ್ರಾಧಿಕಾರ - ಔಷಧ ಬೆಲೆ ಮತ್ತು ವ್ಯಾಪಾರ ಅಂಚು ನಿಯಂತ್ರಿಸುತ್ತದೆ. • ಔಷಧ ಗುಣಮಟ್ಟ ನಿಯಂತ್ರಣ ಸಂಸ್ಥೆ - ತಪ್ಪು. • ಆಹಾರ ಸುರಕ್ಷತಾ ಪ್ರಾಧಿಕಾರ - ತಪ್ಪು. • ಔಷಧಾಲಯ ಪರಿಷತ್ತು - ತಪ್ಪು.
Convert this topic into marks
Today's 10-MCQ test · instant analysis · Powered by AdaptIQ